Yixiang Shi
Research Subjects
Yixiang Shi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Baoqing Jia
Department of General Surgery, Chinese PLA General Hospital, Beijing, People’s Republic of China
39 shared publications - Chuan He
Department of Chemistry, University of Chicago, Chicago, USA
39 shared publications - Dongdong Li
Shanghai Epican Genetech Co., Ltd., Shanghai, China. 12
39 shared publications - Guodong He
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. 1
39 shared publications - Guoqiang Su
Department of Colorectal Tumor Surgery Xiamen Key Laboratory of Early Cancer Diagnosis and Treatment School of Medicine The First Affiliated Hospital of Xiamen University Xiamen University Xiamen Fujian China
39 shared publications - Jia Fan
Fudan University
39 shared publications
Latest Publications
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Distribution of unique mapped reads in the 24-pooling libraries.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Distribution of unique mapped reads in the 24-pooling libraries.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
The 5hmC diagnostic model for CRC/AA detects stage I-III CRC missed by CEA in the external validation set.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
The 5hmC diagnostic model for CRC/AA detects stage I-III CRC missed by CEA in the external validation set.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Evaluation of library construction for the 24-pooling samples Our aim was to establish the 5hmC-Seal in cfDNA samples as a robust, convenient, and cost-efficient approach for clinical applications. Therefore, in this study, we also
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Evaluation of library construction for the 24-pooling samples Our aim was to establish the 5hmC-Seal in cfDNA samples as a robust, convenient, and cost-efficient approach for clinical applications. Therefore, in this study, we also
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Representativeness of Study Participants
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Representativeness of Study Participants
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Participant demographics in training, internval validation, and external validation sets.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Participant demographics in training, internval validation, and external validation sets.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Performance of single marker genes for distinguishing CRC/AA from controls.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Performance of single marker genes for distinguishing CRC/AA from controls.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
The 5hmC diagnostic model for CRC/AA detects patients with stage IV CRC in the validation sets.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
The 5hmC diagnostic model for CRC/AA detects patients with stage IV CRC in the validation sets.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Performance of the 5hmC diagnostic model for CRC/AA in distinguishing stage I-III CRC and AA.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Performance of the 5hmC diagnostic model for CRC/AA in distinguishing stage I-III CRC and AA.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Differentially modified genes and tissue relevance.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Differentially modified genes and tissue relevance.
- Open Access
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Participant demographics in training, internval validation, and external validation sets.
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study
Participant demographics in training, internval validation, and external validation sets.